GPhA policy (correction)
Executive Summary
The Generic Pharmaceutical Association supports the goal of the Food and Drug Import Safety Act, but the association does not endorse the use of import fees to improve FDA's foreign inspection program. A previous article indicated that GPhA supports the proposed legislation (1"The Pink Sheet" Aug. 13, 2007, p. 21)...
You may also be interested in...
Inspection Of Rx Imports Would Climb Under Bill Setting $300 Mil. In User Fees
Drug import fees totaling $300 million each in fiscal years 2008 through 2012 would be authorized by a food and drug import safety bill being developed by House Energy and Commerce Committee Chairman John Dingell, D-Mich
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.